ArticleOncogene2026

Cereblon (CRBN) inhibits prostate cancer metastasis by negatively regulating 6-phosphogluconate dehydrogenase (6PGD).

Koushik Guchhait et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.